PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE

PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 110 (tempo di esecuzione: 0.011 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial 01 - Articolo su rivista 2024 Pieruzzi, F +
Interpretation of GFR slope in untreated and treated adult Fabry patients 01 - Articolo su rivista 2024 Pieruzzi, Federico +
PICC insertion and veins of the arm size variation during dialysis treatment: A prospective observational study 01 - Articolo su rivista 2024 Lucchini, AlbertoPieruzzi, FedericoElli, Stefano +
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study 01 - Articolo su rivista 2024 Pieruzzi, Federico +
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 01 - Articolo su rivista 2023 Pieruzzi F. +
Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis 01 - Articolo su rivista 2023 Pieruzzi, Federico +
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study 01 - Articolo su rivista 2023 Genovesi, SRebora, PPieruzzi, F +
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan 01 - Articolo su rivista 2023 Pieruzzi F. +
An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease 01 - Articolo su rivista 2022 Pieruzzi F. +
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 99 - Altro 2022 Salerno F. R.Roggero L.Binaggia A.Pieruzzi F. +
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 01 - Articolo su rivista 2022 Lacetera R.Roggero L.Vercelloni P.Uzzo M.Carbone M.Invernizzi P.L'Imperio V.Pieruzzi F.Sinico R. A.
Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy 01 - Articolo su rivista 2022 Pieruzzi F. +
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 01 - Articolo su rivista 2022 Pieruzzi F. +
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 01 - Articolo su rivista 2022 Grassi, GuidoFowler, BiancaScali, BeatriceMotto, ElenaPieruzzi, FedericoMancia, Giuseppe +
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 01 - Articolo su rivista 2022 Moroni, FrancescoPieruzzi, Federico +
α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response 01 - Articolo su rivista 2022 Pieruzzi F. +
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 01 - Articolo su rivista 2021 Pieruzzi, Federico +
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 01 - Articolo su rivista 2021 Pieruzzi F. +
Avacopan for the treatment of ANCA-associated vasculitis 01 - Articolo su rivista 2021 Pieruzzi, F +
Correction to: Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis (Journal of Nephrology, (2020), 10.1007/s40620-020-00774-5) 99 - Altro 2021 Genovesi S.Pieruzzi F.Contaldo G.Rebora P.Valsecchi M. +